Pongo abelii (Sumatran orangutan)
| UniProt ID | Protein Name | Gene Symbol ▲ | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
|---|---|---|---|---|---|
| Q5R893 | Histone H2B type 1 |
|
1 | 0 |
|
| Q5RCL0 | Uncharacterized protein C11orf87 homolog |
|
2 | 0 |
|
| Q5R4N8 | Alpha-2-macroglobulin |
|
8 | 0 |
|
| Q5R536 | Alpha-1-antichymotrypsin |
|
5 | 0 |
|
| Q5R8Y5 | Neutral cholesterol ester hydrolase 1 |
|
3 | 0 |
|
| Q5RFR6 | Dyslexia-associated protein KIAA0319-like protein |
|
3 | 0 |
|
| Q2IBE4 | Cystic fibrosis transmembrane conductance regulator |
|
2 | 0 |
|
| H2NUD7 | Angiotensin-converting enzyme |
|
15 | 0 |
|
| A0A8I5UU05 | Angiotensin-converting enzyme |
|
6 | 0 |
|
| A0A8I5T0J2 | Angiotensin-converting enzyme |
|
6 | 0 |
|
| A0A2J8W4D8 | Angiotensin-converting enzyme |
|
4 | 0 |
|
| Q5RFN1 | Angiotensin-converting enzyme 2 |
|
7 | 0 |
|
| Q5NVF6 | Lysosomal acid phosphatase |
|
8 | 0 |
|
| A0A2J8RYI8 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
| Q5RAN0 | Activin receptor type-1-like |
|
1 | 0 |
|
| Q5RC46 | Adenosine deaminase 2 |
|
4 | 0 |
|
| H2P2U3 | ADAM metallopeptidase with thrombospondin type 1 motif 1 |
|
3 | 0 |
|
| Q5RFQ8 | A disintegrin and metalloproteinase with thrombospondin motifs 4 |
|
1 | 0 |
|
| H2P2U4 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
2 | 0 |
|
| Q5R7Y0 | Adhesion G protein-coupled receptor B2 |
|
8 | 0 |
|
| Q5RF57 | Adenosine receptor A1 |
|
2 | 0 |
|
| Q5RD44 | Anion exchange protein 2 |
|
3 | 0 |
|
| Q5R6J7 | Glycerol-3-phosphate acyltransferase 4 |
|
4 | 0 |
|
| Q5NVS8 | Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase |
|
1 | 0 |
|
| Q5R7M3 | Amphoterin-induced protein 2 |
|
7 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025